You just read:

MabVax Therapeutics Enrolls First Patients in Expansion of Phase I Clinical Trial Treating Newly Diagnosed Pancreatic Cancer Patients

News provided by

MabVax Therapeutics Holdings, Inc.

Nov 28, 2016, 08:00 ET